AbbVie Faces Extended U.S. Antitrust Review for Allergan Deal

(Bloomberg) -- AbbVie Inc.’s deal to buy Botox maker Allergan Plc will undergo an in-depth investigation by U.S. antitrust enforcers.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.